Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Enhanced potency of the metalloprotease inhibitor TAPI-2 by multivalent display.

Raissi AJ, Scangarello FA, Hulce KR, Pontrello JK, Paradis S.

Bioorg Med Chem Lett. 2014 Apr 15;24(8):2002-7. doi: 10.1016/j.bmcl.2014.02.007. Epub 2014 Feb 14.

2.

Metalloprotease inhibitors GM6001 and TAPI-0 inhibit the obligate intracellular human pathogen Chlamydia trachomatis by targeting peptide deformylase of the bacterium.

Balakrishnan A, Patel B, Sieber SA, Chen D, Pachikara N, Zhong G, Cravatt BF, Fan H.

J Biol Chem. 2006 Jun 16;281(24):16691-9. Epub 2006 Mar 24.

3.

A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor.

Müllberg J, Durie FH, Otten-Evans C, Alderson MR, Rose-John S, Cosman D, Black RA, Mohler KM.

J Immunol. 1995 Dec 1;155(11):5198-205.

PMID:
7594530
4.
5.

Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells.

Codony-Servat J, Albanell J, Lopez-Talavera JC, Arribas J, Baselga J.

Cancer Res. 1999 Mar 15;59(6):1196-201.

6.

Angiotensin-converting enzyme secretase is inhibited by zinc metalloprotease inhibitors and requires its substrate to be inserted in a lipid bilayer.

Parvathy S, Oppong SY, Karran EH, Buckle DR, Turner AJ, Hooper NM.

Biochem J. 1997 Oct 1;327 ( Pt 1):37-43.

7.

Identifying common metalloprotease inhibitors by protein fold types using Fourier transform mass spectrometry.

Mitchell JK, Pitcher D, McArdle BM, Alnefelt T, Duffy S, Avery V, Quinn RJ.

Bioorg Med Chem Lett. 2007 Dec 1;17(23):6521-4. Epub 2007 Sep 29.

PMID:
17933532
8.

Molecular diversity of hydroxamic acids: part II. Potential therapeutic applications.

Lou B, Yang K.

Mini Rev Med Chem. 2003 Sep;3(6):609-20. Review.

PMID:
12871163
9.

Metalloprotease disintegrin-mediated ectodomain shedding of EGFR ligands promotes intestinal epithelial restitution.

Myhre GM, Toruner M, Abraham S, Egan LJ.

Am J Physiol Gastrointest Liver Physiol. 2004 Dec;287(6):G1213-9. Epub 2004 Jul 29.

10.
11.

Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism.

Bakken AM, Protack CD, Roztocil E, Nicholl SM, Davies MG.

J Vasc Surg. 2009 May;49(5):1296-303. doi: 10.1016/j.jvs.2008.12.026.

12.

Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.

Kruse MN, Becker C, Lottaz D, Köhler D, Yiallouros I, Krell HW, Sterchi EE, Stöcker W.

Biochem J. 2004 Mar 1;378(Pt 2):383-9.

13.

A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy.

Sommer C, Schmidt C, George A, Toyka KV.

Neurosci Lett. 1997 Nov 14;237(1):45-8.

PMID:
9406876
14.

Involvement of caspases and transmembrane metalloproteases in sulphur mustard-induced microvesication in adult human skin in organ culture: directions for therapy.

Mol MA, van den Berg RM, Benschop HP.

Toxicology. 2009 Apr 5;258(1):39-46. doi: 10.1016/j.tox.2009.01.004. Epub 2009 Jan 9.

PMID:
19167455
15.

Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor.

Mori M, Moraca F, Deodato D, Ferraris DM, Selchow P, Sander P, Rizzi M, Botta M.

Bioorg Med Chem Lett. 2014 Jun 1;24(11):2508-11. doi: 10.1016/j.bmcl.2014.04.004. Epub 2014 Apr 13.

PMID:
24767848
16.

Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation.

Saito S, Frank GD, Motley ED, Dempsey PJ, Utsunomiya H, Inagami T, Eguchi S.

Biochem Biophys Res Commun. 2002 Jun 28;294(5):1023-9.

PMID:
12074579
17.

Rapid assembly of matrix metalloprotease inhibitors using click chemistry.

Wang J, Uttamchandani M, Li J, Hu M, Yao SQ.

Org Lett. 2006 Aug 17;8(17):3821-4.

PMID:
16898826
18.

Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity.

Burnett JC, Schmidt JJ, Stafford RG, Panchal RG, Nguyen TL, Hermone AR, Vennerstrom JL, McGrath CF, Lane DJ, Sausville EA, Zaharevitz DW, Gussio R, Bavari S.

Biochem Biophys Res Commun. 2003 Oct 10;310(1):84-93.

PMID:
14511652
19.

Identification and activity of inhibitors of the essential nematode-specific metalloprotease DPY-31.

France DJ, Stepek G, Houston DR, Williams L, McCormack G, Walkinshaw MD, Page AP.

Bioorg Med Chem Lett. 2015 Dec 15;25(24):5752-5. doi: 10.1016/j.bmcl.2015.10.077. Epub 2015 Nov 3.

20.

Developing photoactive affinity probes for proteomic profiling: hydroxamate-based probes for metalloproteases.

Chan EW, Chattopadhaya S, Panicker RC, Huang X, Yao SQ.

J Am Chem Soc. 2004 Nov 10;126(44):14435-46.

PMID:
15521763

Supplemental Content

Support Center